Cardiovascular Systems Revenue and Competitors



Total Funding

Estimated Revenue & Valuation

  • Cardiovascular Systems's estimated annual revenue is currently $256.8M per year.(i)
  • Cardiovascular Systems received $40.0M in venture funding in April 2017.
  • Cardiovascular Systems's estimated revenue per employee is $482,707
  • Cardiovascular Systems's total funding is $98M.
  • Cardiovascular Systems's current valuation is $777.8M. (January 2022)

Employee Data

  • Cardiovascular Systems has 532 Employees.(i)
  • Cardiovascular Systems grew their employee count by -33% last year.

Cardiovascular Systems's People

Area VPReveal Email/Phone
VP, National AccountsReveal Email/Phone
VP, Peripheral SalesReveal Email/Phone
Corporate Compliance OfficerReveal Email/Phone
VP - Marketing and Commercial OperationsReveal Email/Phone
VP & General Manager, Peripheral SalesReveal Email/Phone
VP, Corporate Development and Intellectual PropertyReveal Email/Phone
VP, Product DevelopmentReveal Email/Phone
VP, Investor Relations & Corporate CommunicationsReveal Email/Phone
Director Sales EnablementReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
Add Company

What Is Cardiovascular Systems?

Cardiovascular Systems, Inc. (CSI) is devoted to developing and commercializing innovative solutions for treating peripheral and coronary vascular disease. Our primary focus is helping physicians conquer even the most difficult disease states, including arterial calcium, given the complications it presents for the millions who suffer from peripheral arterial disease (PAD) and coronary artery disease (CAD). CSI is committed to clinical rigor, constant innovation, and a defining drive to set the standard in safe, effective, economical medical devices that improve patient outcomes.

keywords:Biotechnology,Healthcare,Medical Devices,Pharmaceuticals


Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Cardiovascular Systems News

2022-04-17 - Do Analysts Agree Thursday on Cardiovascular Systems Inc (CSII) Stock's Target Price?

Do Analysts Agree Thursday on Cardiovascular Systems Inc (CSII) Stock's Target Price? Thursday, April 21, 2022 12:04 PM | InvestorsObserver Analysts.

2022-04-13 - Cardiovascular Systems, Inc. to Host Earnings Conference ...

--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) plans to announce its operating results for the quarter ended March 31,...

2022-04-13 - Here's Why You Should Hold on to Cardiovascular Systems (CSII)

Cardiovascular Systems reported a loss of 23 cents per share for second-quarter fiscal 2022, wider than the Zacks Consensus Estimate of a...

2018-01-18 - Cardiovascular Systems inks partnerships with OrbusNeich, Integer

Cardiovascular Systems (Nasdaq: CSII) announced today that it is expanding its product portfolio through new partnerships with OrbusNeich and Integer. The OrbusNeich partnership makes St. Paul, Minn.–based CSI the exclusive U.S. distributor of Hong Kong–based OrbusNeich‘s balloon products. The ...

2010-08-11 - More progress for Cardiovascular Systems in fiscal 2010

Bolstered by a 15 percent increase in revenues from year-ago levels — all but a relative sliver coming from reorders — Cardiovascular Systems Inc. (NSDQ:CSII) narrowed its net loss by $1.2 million, to $4.4 million, during the final three months of its 2010 fiscal year. The St. Paul, Minn.-based ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding

Cardiovascular Systems Funding

DateAmountRoundLead InvestorsReference
2006-08-01$25.0MUndisclosedEaston Capital Group, Maverick Capital FundsArticle
2006-09-20$25.0MAEaston Capital Partners L.PArticle
2010-04-21$29.0MUndisclosedSilicon Valley BankArticle
2017-04-05$40.0MUndisclosedSilicon Valley BankArticle